In March 2015, the Global TB Community Advisory Board (TB CAB) and 84 other organizations including, Medicines Sans Frontiers (MSF), Action Global Health Advocacy Partnership, Swift Response Project, Treatment Action Campaign (TAC), and Treatment Action Group (TAG), called on global health actors to take steps to ensure access to new and repurposed TB drugs. The letter called on global funders, procurement agencies, and organizations to work with governments and in-country partners to accelerate access to DR-TB drugs in 52 countries by 2019; and sponsors of TB drugs to rapidly and widely register their products and to create transparent and fair pricing and licensing policies for low- and middle-income countries Source- Global TB Community Advisory Board (TB CAB)